These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14756711)

  • 21. The epidemiology of ecstasy use and harms in Australia.
    Degenhardt L; Roxburgh A; Dunn M; Campbell G; Bruno R; Kinner SA; George J; Quinn B; White N; Topp L
    Neuropsychobiology; 2009; 60(3-4):176-87. PubMed ID: 19893334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pills and pints: risky drinking and alcohol-related harms among regular ecstasy users in Australia.
    Kinner SA; George J; Johnston J; Dunn M; Degenhardt L
    Drug Alcohol Rev; 2012 May; 31(3):273-80. PubMed ID: 21919977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
    Daumann J; Hensen G; Thimm B; Rezk M; Till B; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2004 May; 173(3-4):398-404. PubMed ID: 14722704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study.
    Southey M; Kathirgamalingam A; Crawford B; Kaul R; McNamara J; John-Leader F; Heslop J; Pit SW
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):55. PubMed ID: 32758263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Getting into ecstasy: comparing moderate and heavy young adult users.
    Sterk CE; Theall KP; Elifson KW
    J Psychoactive Drugs; 2007 Jun; 39(2):103-13. PubMed ID: 17703705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM; Parrott AC; Schifano F; Turner JJ
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study.
    Hopper JW; Su Z; Looby AR; Ryan ET; Penetar DM; Palmer CM; Lukas SE
    Drug Alcohol Depend; 2006 Dec; 85(3):221-35. PubMed ID: 16730923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Young adults' recreational social environment as a predictor of ecstasy use initiation: findings of a population-based prospective study.
    Smirnov A; Najman JM; Hayatbakhsh R; Wells H; Legosz M; Kemp R
    Addiction; 2013 Oct; 108(10):1809-17. PubMed ID: 23668641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-reported psychopathology among young, low-income, female ecstasy users.
    Wu ZH; Baillargeon JG; Berenson AB; Holzer CE
    J Addict Dis; 2008; 27(4):81-90. PubMed ID: 19042593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns and harms of pharmaceutical drug use among ecstasy users in Australia.
    Silins E; Copeland J; Dillon P
    Adicciones; 2009; 21(4):347-62. PubMed ID: 20011991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of ecstasy use among students surveyed through the 1997 College Alcohol Study.
    Yacoubian GS
    J Drug Educ; 2003; 33(1):61-9. PubMed ID: 12773025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ; McFie L; Fleetwood H; Robinson JA
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.